Wed, September 5, 2012
Tue, September 4, 2012
Mon, September 3, 2012
Sun, September 2, 2012
Sat, September 1, 2012
Fri, August 31, 2012
Thu, August 30, 2012
Wed, August 29, 2012
Tue, August 28, 2012
Mon, August 27, 2012
Sun, August 26, 2012
Sat, August 25, 2012
Fri, August 24, 2012
Thu, August 23, 2012
Wed, August 22, 2012
[ Wed, Aug 22nd 2012 ] - Market Wire
Inergetics Shareholder Update
Tue, August 21, 2012

Watson to Present at the 2012 Bank of America Merrill Lynch Global Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. -merrill-lynch-global-healthcare-conference.html
Published in Health and Fitness on Wednesday, August 29th 2012 at 6:45 GMT by Market Wire   Print publication without navigation


Watson to Present at the 2012 Bank of America Merrill Lynch Global... -- PARSIPPANY, N.J., Aug. 29, 2012 /PRNewswire/ --

Watson to Present at the 2012 Bank of America Merrill Lynch Global Healthcare Conference

[ ]
[ ]

PARSIPPANY, N.J., Aug. 29, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: [ WPI ]), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's President and Chief Executive Officer, will provide an overview and update of the Company's business at the 2012 Bank of America Merrill Lynch Global Healthcare Conference on Wednesday, September 12, 2012 at 10:25AM Eastern Time (3:25PM London Time) at Merrill Lynch Financial Center in London. The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at [ http://ir.watson.com ].  The webcast can also be accessed at the following URL:

[ http://www.media-server.com/m/p/8qogd5t2 ]

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

(Logo: [ http://photos.prnewswire.com/prnh/20100121/LA41294LOGO ] )

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. The Company is also developing biosimilar products in Women's Health and Oncology.  Additionally, Watson distributes generic and branded pharmaceuticals through its Anda, Inc. distribution business. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at [ http://www.watson.com ].

CONTACTS:     

Investors:
Lisa DeFrancesco                                       
(862) 261-7152

Media:
Charlie Mayr
(862) 261-8030

SOURCE Watson Pharmaceuticals, Inc.



[ Back to top ]

RELATED LINKS
[ http://www.watson.com ]


Publication Contributing Sources